Analysis

Zoetis Inc. (NYSE:ZTS) Earnings Preview: Key Financial Insights

02/12/2025

News

Zoetis' Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.

Shares in animal pharmaceutical company Zoetis (ZTS 0.14%) have been under a cloud since the release of the company's fourth-quarter earnings report in mid-February. The Q4 numbers were fine, but the company's revenue guidance fell short of expectations.

03/27/2025

Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, May 6, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2025 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations.

03/27/2025

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Zoetis Inc. (ZTS) a buy, sell, or hold?

Zoetis Inc. (ZTS) can hold. Click on Rating Page for detail.

What is Zoetis Inc.'s stock price?

The price of Zoetis Inc. (ZTS) is 163.595 and it was updated on 2025-04-02 13:00:16.

Is Zoetis Inc. (ZTS) overvalued or undervalued?

Currently Zoetis Inc. (ZTS) is in overvalued.

News

From:

To:

Show entries

Search:

News
Zoetis: Lots Of Growth Opportunities For This High-Quality Compounder Zoetis is currently cheap from a historical perspective, presenting a potential buying opportunity. The company operates in a growing animal healthcare market, benefiting from trends like pet humanization and medicalization, ensuring long-term growth. ZTS has a strong track record of market outperformance, impressive margins, and a high ROIC, making it a high-quality company. Tue, Mar. 25, 2025
Zoetis (ZTS) Stock Declines While Market Improves: Some Information for Investors Zoetis (ZTS) closed the most recent trading day at $163.03, moving -0.08% from the previous trading session. Fri, Mar. 21, 2025
Why Zoetis (ZTS) Dipped More Than Broader Market Today The latest trading day saw Zoetis (ZTS) settling at $160.06, representing a -1% change from its previous close. Thu, Mar. 13, 2025
Zoetis: Focusing On The High Margin Segments The recent divestiture of the MFA segment improves margins and returns on capital. Zoetis is focusing on more profitable segments like genetics and companion animals. The recently updated Librela label includes adverse effects and urges practitioners to discuss potential adverse reactions with clients. Thu, Mar. 13, 2025
Zoetis Inc. (ZTS) CFO Wetteny Joseph Hosts Barclays 27th Annual Global Healthcare (Transcript) Zoetis Inc. (NYSE:ZTS ) Barclays 27th Annual Global Healthcare March 11, 2025 10:30 AM ET Company Participants Wetteny Joseph - Chief Financial Officer Conference Call Participants Balaji Prasad - Barclays Balaji Prasad Good morning, everyone. Thanks for joining us at the Barclays Healthcare Conference. Tue, Mar. 11, 2025

Showing 1 to 5 of 5 entries

Previous1Next

Transcripts

Show entries

Search:

Transcipts Data
Zoetis Inc. (ZTS) on Q3 2024 Results - Earnings Call Transcript SA Transcripts Mon, Nov. 04, 2024
Zoetis Inc. (ZTS) on Q2 2024 Results - Earnings Call Transcript SA Transcripts Tue, Aug. 06, 2024
Zoetis Inc. (ZTS) on Q1 2024 Results - Earnings Call Transcript SA Transcripts Thu, May. 02, 2024
Zoetis Inc. (ZTS) on Q4 2023 Results - Earnings Call Transcript SA Transcripts Wed, Feb. 14, 2024
Zoetis Inc. (ZTS) on Q3 2023 Results - Earnings Call Transcript SA Transcripts Thu, Nov. 02, 2023
Zoetis Inc. (ZTS) on Q2 2023 Results - Earnings Call Transcript SA Transcripts Tue, Aug. 08, 2023
Zoetis Inc. (ZTS) on Q1 2023 Results - Earnings Call Transcript SA Transcripts Thu, May. 04, 2023
Zoetis Inc. (ZTS) on Q4 2022 Results - Earnings Call Transcript SA Transcripts Tue, Feb. 14, 2023
Zoetis Inc. (ZTS) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Thu, Nov. 03, 2022
Zoetis Inc. (ZTS) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Thu, Aug. 04, 2022

Showing 1 to 10 of 14 entries

Previous1 2Next

SEC Filings

Show entries

Search:

SEC Filings
Zoetis Inc. (ZTS) - 4 SEC Filings 02/21/2025
Zoetis Inc. (ZTS) - 4 SEC Filings 02/20/2025
Zoetis Inc. (ZTS) - 4 SEC Filings 02/18/2025
Zoetis Inc. (ZTS) - 8-K - Current report SEC Filings 02/13/2025
Zoetis Inc. (ZTS) - 10-K - Current report SEC Filings 02/13/2025
Zoetis Inc. (ZTS) - 4 SEC Filings 02/11/2025
Zoetis Inc. (ZTS) - 4 SEC Filings 02/10/2025
Zoetis Inc. (ZTS) - 8-K - Current report SEC Filings 02/06/2025
Zoetis Inc. (ZTS) - 8-K - Current report SEC Filings 01/13/2025
Zoetis Inc. (ZTS) - 4 SEC Filings 01/13/2025

Showing 1 to 10 of 542 entries

Previous1 2 3 4 5…55Next

Press Releases

Show entries

Search:

StockPrice Release
Zoetis to host webcast and conference call on first quarter 2025 financial results 03/27/2025
Zoetis receives conditional license from usda for avian influenza vaccine, h5n2 subtype, killed virus 02/14/2025
Zoetis reports fourth quarter and full year 2024 results 02/13/2025
Zoetis declares second quarter 2025 dividend 02/06/2025
Is zoetis inc. (nyse: zts) overvalued? or is it worth buying now? 01/07/2025
Zoetis to host webcast and conference call on fourth quarter and full year 2024 financial results 01/07/2025
Zoetis declares first quarter 2025 dividend; board approves 16% payment increase 12/12/2024
Zoetis appoints jamie brannan to newly created chief commercial officer role 11/11/2024
Zoetis to participate in jefferies london healthcare conference 11/07/2024
Investors are invited to join the schall law firm in an inquiry into zoetis inc. for fraud 11/04/2024

Showing 1 to 10 of 409 entries

Previous1 2 3 4 5…41Next

More Headlines

Show entries

Search:

News
Zoetis (ZTS) Laps the Stock Market: Here's Why Zoetis (ZTS) reachead $170.37 at the closing of the latest trading day, reflecting a +1.87% change compared to its last close. 03/07/2025
My Top 15 High-Growth Dividend Stocks For March 2025 The SPDR S&P 500 ETF Trust stumbled in February but managed to maintain a positive return in 2025. The Top 15 dividend growth stocks for March 2025 offer an average dividend yield of 1.13% and appear to be about 25% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved a 10.63% compound annual growth rate. 03/03/2025
Zoetis Inc. (ZTS) BofA Securities 2025 Animal Health Summit (Transcript) Zoetis Inc. (NYSE:ZTS ) BofA Securities 2025 Animal Health Summit February 27, 2025 1:20 PM ET Company Participants Wetteny Joseph - CFO Conference Call Participants Michael Ryskin - Bank of America Operator Ladies and gentlemen, the program is about to begin. At this time, it is my pleasure to turn the program over to your host, Michael Ryskin. 02/28/2025
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now It is a beautiful thing when you find a feel-good stock that offers market-beating potential. A perfect example of this combination today is animal healthcare specialist Zoetis (ZTS 1.93%). 02/23/2025
Zoetis CEO on bird flu vaccine Zoetis received a conditional license for its bird flu vaccine from the US Department of Agriculture to help fight the spread of the disease on poultry farms. Here's what CEO Kristin Peck had to say 02/18/2025
Why Zoetis Stock Took Another Tumble Today One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (ZTS -4.49%) shares again tumbled. As of late-session trading on Friday, they were down by 4%, in no small part due to several analyst price target cuts. 02/14/2025
US grants conditional clearance to Zoetis' bird flu vaccine for poultry Zoetis said on Friday its bird flu vaccine has received the U.S. Department of Agriculture's conditional license for use in poultry. 02/14/2025
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #HPAI--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labelled for use in chickens. The conditional license was granted on the demonstration of safety, purity, and reasonable expectation of efficacy based on serology data. Zoetis is committed to supporting poultry producers with scientif. 02/14/2025
Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more. 02/13/2025
Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance, presenting a buying opportunity around $163/share. Zoetis' unique advantages and pricing power in animal health, coupled with high R&D investment and a wide moat, make it a strong long-term play on emerging market growth. Despite regulatory risks and currency headwinds, Zoetis' dependable earnings and high operating margins justify a 12-month price target of $200/share. 02/13/2025

Showing 1 to 10 of 614 entries

Previous1 2 3 4 5…62Next

Unlock

ZTS Ratings Summary

Quant

Neutral

ZTS Quant Ranking

Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Quant Rating	Neutral
Quant Score	3

Is Zoetis Inc. (ZTS) a buy, sell, or hold?

What is Zoetis Inc.'s stock price?

Is Zoetis Inc. (ZTS) overvalued or undervalued?

Zoetis (ZTS) Laps the Stock Market: Here's Why

My Top 15 High-Growth Dividend Stocks For March 2025

Zoetis Inc. (ZTS) BofA Securities 2025 Animal Health Summit (Transcript)

A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now

Zoetis CEO on bird flu vaccine

Why Zoetis Stock Took Another Tumble Today

US grants conditional clearance to Zoetis' bird flu vaccine for poultry

Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus

Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval

Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity

Company Details

Ratings

Quant Factor Grades

Trading

Dividend Grades

Dividend

Earnings

Valuation

Growth

Performance

Momentum

Profitability

Risk

Ownership

Debt